skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural basis for potency differences between GDF8 and GDF11

Journal Article · · BMC Biology
 [1];  [1];  [1];  [1];  [2];  [3];  [3];  [4];  [5];  [6];  [6];  [7];  [5];  [4];  [3];  [2];  [1]
  1. Univ. of Cincinnati, OH (United States)
  2. Harvard Univ., Cambridge, MA (United States)
  3. Harvard Univ., Cambridge, MA (United States); Harvard Medical School, Boston, MA (United States)
  4. Michigan State Univ., East Lansing, MI (United States)
  5. Hudson Inst. of Medical Research, Clayton (Australia); Monash Univ., Melbourne, VIC (Australia)
  6. McGill Univ., Montreal, QC (Canada)
  7. Univ. of Pittsburgh School of Medicine, Pittsburgh, PA (United States)

Background: Growth/differentiation factor 8 (GDF8) and GDF11 are two highly similar members of the transforming growth factor β (TGFβ) family. While GDF8 has been recognized as a negative regulator of muscle growth and differentiation, there are conflicting studies on the function of GDF11 and whether GDF11 has beneficial effects on age-related dysfunction. To address whether GDF8 and GDF11 are functionally identical, we compared their signaling and structural properties. Results: Here, in this paper, we show that, despite their high similarity, GDF11 is a more potent activator of SMAD2/3 and signals more effectively through the type I activin-like receptor kinase receptors ALK4/5/7 than GDF8. Resolution of the GDF11:FS288 complex, apo-GDF8, and apo-GDF11 crystal structures reveals unique properties of both ligands, specifically in the type I receptor binding site. Lastly, substitution of GDF11 residues into GDF8 confers enhanced activity to GDF8. Conclusions: These studies identify distinctive structural features of GDF11 that enhance its potency, relative to GDF8; however, the biological consequences of these differences remain to be determined.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
National Institutes of Health (NIH); National Health and Medical Research Council Australia; Michigan State University; Paul F. Glenn Center for the Biology of Aging; Muscular Dystrophy Association (MDA); University of Cincinnati Graduate Dean Fellowship; American Heart Association (AHA); Paul F. Glenn Center Grant
Grant/Contract Number:
R01AG047131; R01AG040019; R03AG049657; R56AG048917; R56AG052979; R01AG048917; R41AR06880401; GM58670; CA172886; CIHR MOP-133394; 1078907; R01GM114640; 240087; 12PRE11790027
OSTI ID:
1357654
Journal Information:
BMC Biology, Vol. 15, Issue 1; ISSN 1741-7007
Publisher:
BioMed CentralCopyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 73 works
Citation information provided by
Web of Science

References (100)

Electrostatics of nanosystems: Application to microtubules and the ribosome journal August 2001
Energetic Characterization of the Basic Fibroblast Growth Factor-Heparin Interaction: Identification of the Heparin Binding Domain journal April 1994
Vascular and Neurogenic Rejuvenation of the Aging Mouse Brain by Young Systemic Factors journal May 2014
Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis journal March 2014
Gdf-8 Propeptide Binds to GDF-8 and Antagonizes Biological Activity by Inhibiting GDF-8 Receptor Binding journal January 2001
Ternary Complex of Transforming Growth Factor-β1 Reveals Isoform-specific Ligand Recognition and Receptor Recruitment in the Superfamily journal March 2010
Molecular recognition of BMP-2 and BMP receptor IA journal April 2004
Structural insights into BMP receptors: Specificity, activation and inhibition journal February 2016
A Novel Role of Follistatin, an Activin-binding Protein, in the Inhibition of Activin Action in Rat Pituitary Cells: ENDOCYTOTIC DEGRADATION OF ACTIVIN AND ITS ACCELERATION BY FOLLISTATIN ASSOCIATED WITH CELL-SURFACE HEPARAN SULFATE journal May 1997
Restoring Systemic GDF11 Levels Reverses Age-Related Dysfunction in Mouse Skeletal Muscle journal May 2014
Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5) journal February 2002
Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand: Type I receptor specificity of BMP-6 journal December 2007
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy journal May 2013
A Flexible Activin Explains the Membrane-Dependent Cooperative Assembly of TGF-β Family Receptors journal August 2004
Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates journal November 2009
Structural basis for the inhibition of activin signalling by follistatin journal February 2006
Differential regulation of follicle stimulating hormone by activin A and TGFB1 in murine gonadotropes journal December 2005
The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding journal July 2009
Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors journal November 1993
Structural basis for specificity of TGFβ family receptor small molecule inhibitors journal February 2012
A Novel BMP Expressed in Developing Mouse Limb, Spinal Cord, and Tail Bud Is a Potent Mesoderm Inducer inXenopusEmbryos journal April 1999
Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody journal July 2016
Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11 journal July 1999
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size journal June 2009
TGFβ Signaling and Cardiovascular Diseases journal January 2012
GDF11 Controls the Timing of Progenitor Cell Competence in Developing Retina journal June 2005
The Myostatin Propeptide and the Follistatin-related Gene Are Inhibitory Binding Proteins of Myostatin in Normal Serum journal August 2002
A Single Residue of GDF-5 Defines Binding Specificity to BMP Receptor IB journal June 2005
Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone β subunit transcription journal February 2007
Activin B can signal through both ALK4 and ALK7 in gonadotrope cells journal October 2006
Myostatin Signals through a Transforming Growth Factor  -Like Signaling Pathway To Block Adipogenesis journal September 2003
Biological Activity of Follistatin Isoforms and Follistatin-Like-3 Is Dependent on Differential Cell Surface Binding and Specificity for Activin, Myostatin, and Bone Morphogenetic Proteins journal July 2006
Gene Therapy for Duchenne Muscular Dystrophy: Expectations and Challenges journal September 2007
Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease journal March 2009
Lack of evidence for GDF11 as a rejuvenator of aged skeletal muscle satellite cells journal March 2016
Inhibin A and B in Vitro Bioactivities Are Modified by Their Degree of Glycosylation and Their Affinities to Betaglycan journal May 2007
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member journal May 1997
Crystal structure of human GDF11 journal February 2016
Reduced Circulating GDF11 Is Unlikely Responsible for Age-Dependent Changes in Mouse Heart, Muscle, and Brain journal November 2015
Repulsive guidance molecule is a structural bridge between neogenin and bone morphogenetic protein journal May 2015
Gdf11 Is a Negative Regulator of Chondrogenesis and Myogenesis in the Developing Chick Limb journal January 2001
Growth and differentiation factor-11 is developmentally regulated in skeletal muscle and inhibits myoblast differentiation journal January 2012
Development of a Small-Molecule Screening Method for Inhibitors of Cellular Response to Myostatin and Activin A journal August 2013
The bright and the dark sides of activin in wound healing and cancer journal September 2012
Biological Activity Differences between TGF-β1 and TGF-β3 Correlate with Differences in the Rigidity and Arrangement of Their Component Monomers journal September 2014
Induction of Cachexia in Mice by Systemically Administered Myostatin journal May 2002
BMP signalling: agony and antagony in the family journal May 2015
Regulation of myostatin activity and muscle growth journal July 2001
Activin isoforms signal through type I receptor serine/threonine kinase ALK7 journal May 2004
GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration journal July 2015
Conformation and Self-association of Human Recombinant Transforming Growth Factor-β3 in Aqueous Solutions journal March 1999
Mammalian BMP-1/Tolloid-Related Metalloproteinases, Including Novel Family Member Mammalian Tolloid-Like 2, Have Differential Enzymatic Activities and Distributions of Expression Relevant to Patterning and Skeletogenesis journal September 1999
Structure of Myostatin·Follistatin-like 3: N-TERMINAL DOMAINS OF FOLLISTATIN-TYPE MOLECULES EXHIBIT ALTERNATE MODES OF BINDING journal November 2011
Structure of the ternary signaling complex of a TGF-beta superfamily member journal May 2006
GDF11 Does Not Rescue Aging-Related Pathological Hypertrophy journal November 2015
Latent TGF-β structure and activation journal June 2011
GDF11 modulates NGN3+ islet progenitor cell number and promotes  -cell differentiation in pancreas development journal November 2004
Heparin and Activin-Binding Determinants in Follistatin and FSTL3 journal January 2005
Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2 journal September 2013
The Structure of the Follistatin:Activin Complex Reveals Antagonism of Both Type I and Type II Receptor Binding journal October 2005
The Structure of FSTL3·Activin A Complex journal September 2008
Differential Binding Activity of TGF-  Family Proteins to Select TGF-  Receptors journal June 2016
Direct binding of Smad3 and Smad4 to critical TGFbeta -inducible elements in the promoter of human plasminogen activator inhibitor-type 1gene journal June 1998
Cooperative Assembly of TGF-β Superfamily Signaling Complexes Is Mediated by Two Disparate Mechanisms and Distinct Modes of Receptor Binding journal February 2008
Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542 journal July 2002
Circulating Growth Differentiation Factor 11/8 Levels Decline With Age journal January 2016
Crystal structure of human bone morphogenetic protein-2 at 2.7 Å resolution 1 1Edited by R. Huber journal March 1999
Extracellular Regulation of Myostatin: A Molecular Rheostat for Muscle Mass journal December 2010
Double muscling in cattle due to mutations in the myostatin gene journal November 1997
Regulation of Myostatin in Vivo by Growth and Differentiation Factor-Associated Serum Protein-1: A Novel Protein with Protease Inhibitor and Follistatin Domains journal June 2003
The function of growth/differentiation factor 11 (Gdf11) in rostrocaudal patterning of the developing spinal cord journal August 2006
Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions journal April 2003
Characterization of Follistatin-Type Domains and Their Contribution to Myostatin and Activin A Antagonism journal July 2012
Characterization and identification of the inhibitory domain of GDF-8 propeptide journal March 2004
SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7 journal July 2002
Functional improvement of dystrophic muscle by myostatin blockade journal November 2002
A human protein containing multiple types of protease-inhibitory modules journal March 2001
Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases journal December 2003
Growth differentiation factor 11 signals through the transforming growth factor-β receptor ALK5 to regionalize the anterior–posterior axis journal July 2006
Gene Therapy for Duchenne Muscular Dystrophy book June 2010
Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin journal June 1994
TGFβ Signaling and Cardiovascular Diseases journal January 2012
Understanding the role of Cripto-1 in cancer progression and therapeutic strategies journal December 2022
Cloning of a TGF$beta; type I receptor that forms a heteromeric complex with the TGF$beta; type II receptor journal November 1993
Purification and characterization of recombinant human activin B journal June 1990
Inhibition of myostatin in adult mice increases skeletal muscle mass and strength journal January 2003
Autoregulation of Neurogenesis by GDF11 journal January 2003
Biological functions of the WAP domain-containing multidomain proteins WFIKKN1 and WFIKKN2 journal September 2011
Alternative Binding Modes Identified for Growth and Differentiation Factor-associated Serum Protein (GASP) Family Antagonism of Myostatin journal February 2015
Dynamics-modulated Biological Activity of Transforming Growth Factor β3 journal September 2002
Structural and Biophysical Coupling of Heparin and Activin Binding to Follistatin Isoform Functions journal April 2007
Identification of a Novel Pool of Extracellular Pro-myostatin in Skeletal Muscle journal January 2008
Both WFIKKN1 and WFIKKN2 Have High Affinity for Growth and Differentiation Factors 8 and 11 journal July 2008
A Transforming Growth Factor β Type I Receptor that Signals to Activate Gene Expression journal January 1994
Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. journal June 1994
GDF11 Forms a Bone Morphogenetic Protein 1-Activated Latent Complex That Can Modulate Nerve Growth Factor-Induced Differentiation of PC12 Cells journal June 2005
Is Growth Differentiation Factor 11 a Realistic Therapeutic for Aging-Dependent Muscle Defects? journal April 2016
Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation journal April 2016
Redundancy of myostatin and growth/differentiation factor 11 function journal March 2009
Distinct Expression Pattern of Two Related Human Proteins Containing Multiple Types of Protease-Inhibitory Modules journal January 2002

Cited By (27)

Mutations in GDF11 and the extracellular antagonist, Follistatin, as a likely cause of Mendelian forms of orofacial clefting in humans journal June 2019
Precise editing of myostatin signal peptide by CRISPR/Cas9 increases the muscle mass of Liang Guang Small Spotted pigs journal January 2020
The Growth Differentiation Factor 11 is Involved in Skin Fibroblast Ageing and is Induced by a Preparation of Peptides and Sugars Derived from Plant Cell Cultures journal January 2019
Variation in zygotic CRISPR/Cas9 gene editing outcomes generates novel reporter and deletion alleles at the Gdf11 locus journal December 2019
Advances in the molecular regulation of endothelial BMP9 signalling complexes and implications for cardiovascular disease journal May 2019
Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy journal November 2017
Molecular characterization of latent GDF8 reveals mechanisms of activation journal January 2018
Structural characterization of an activin class ternary receptor complex reveals a third paradigm for receptor specificity journal July 2019
Growth differentiation factor 8 regulates SMAD2/3 signaling and improves oocyte quality during porcine oocyte maturation in vitro† journal April 2019
Relationship between serum level of growth differentiation factors 8, 11 and bone mineral density in girls with anorexia nervosa journal October 2018
Follistatin-288-Fc Fusion Protein Promotes Localized Growth of Skeletal Muscle journal December 2018
GDF11 Decreases Pressure Overload–Induced Hypertrophy, but Can Cause Severe Cachexia and Premature Death journal November 2018
Structural biology of the TGFβ family journal October 2019
Structure of the human myostatin precursor and determinants of growth factor latency journal December 2017
Tolloid cleavage activates latent GDF8 by priming the pro‐complex for dissociation journal December 2017
Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis journal July 2017
GDF11 Modulates Ca2+-Dependent Smad2/3 Signaling to Prevent Cardiomyocyte Hypertrophy journal May 2018
A counter gradient of Activin A and follistatin instructs the timing of hair cell differentiation in the murine cochlea journal June 2019
JNK regulates muscle remodeling via myostatin/SMAD inhibition journal August 2018
Growth Differentiation Factor 11 treatment leads to neuronal and vascular improvements in the hippocampus of aged mice journal November 2018
Structure of the human myostatin precursor and determinants of growth factor latency. text January 2018
Advances in the molecular regulation of endothelial BMP9 signalling complexes and implications for cardiovascular disease text January 2019
Exogenous GDF11, but not GDF8, reduces body weight and improves glucose homeostasis in mice journal March 2020
GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone journal February 2020
GDF11 Implications in Cancer Biology and Metabolism. Facts and Controversies journal October 2019
Commentary: Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy journal April 2018
GDF11 induces differentiation and apoptosis and inhibits migration of C17.2 neural stem cells via modulating MAPK signaling pathway journal September 2018


Similar Records

Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11
Journal Article · Wed Feb 27 00:00:00 EST 2019 · Journal of Biological Chemistry · OSTI ID:1357654

Structural characterization of an activin class ternary receptor complex reveals a third paradigm for receptor specificity
Journal Article · Wed Jul 17 00:00:00 EDT 2019 · Proceedings of the National Academy of Sciences of the United States of America · OSTI ID:1357654

Partial inhibition of activin receptor-like kinase 4 alleviates bladder fibrosis caused by bladder outlet obstruction
Journal Article · Wed Sep 15 00:00:00 EDT 2021 · Experimental Cell Research · OSTI ID:1357654